Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Vaccine

Moderna's Key Patent Win Overshadowed By Gloomy Outlook

Moderna Inc. (NASDAQ:MRNA) reported on Friday a second-quarter loss of $2.13 per share, beating the consensus of a $2.98 loss, an improvement from a loss of $3.33 a year ago.

Benzinga

1 Blue-Chip Dividend Stock That Still Has Room to Run

This pharmaceutical leaders offers a combination of growth, income, and innovation.

Barchart

This rare flu complication is on the rise in otherwise healthy children

This year was one of the deadliest flu seasons for children in more than 20 years

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Sanofi's Q2 Earnings Fall Short On Expectations Despite 21% Jump In Dupixent Sales

Sanofi SA (NASDAQ:SNY) reported second-quarter sales of $11.33 billion (€9.99 billion euros), narrowly missing the consensus of $11.53 billion.

Benzinga

RFK Jr.’s ‘information crisis’ has doctors ditching the CDC to save your kids

Real doctors want to help you, unsurprisingly.

We Got This Covered

Moderna Announces 10% Workforce Cut Amid Declining COVID-19 Vaccine Sales, Regulatory Hurdles

Moderna Inc. (NASDAQ:MRNA) has announced plans to reduce its global workforce by approximately 10% by the end of the year due to decreasing COVID-19 vaccine sales and market uncertainty.

Benzinga

Parents urged to prioritise vaccine catch-ups as measles cases remain high

The latest measles data from the UK Health Security Agency shows there have been 145 cases since the last report on July 3.

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

Inside the race to cure cancer: ‘We’re at the cusp of a golden era of treatment’

From new vaccines to predictive AI, Kate Wills investigates whether cancer is about to be beaten

Evening Standard

Vaccine researcher with green card held at San Francisco airport for a week and faces deportation

Family of Tae Heung ‘Will’ Kim, believes detention may be result of South Korean man’s decade-old marijuana misdemeanor

The Independent UK

Experimental HIV vaccines show promise in early safety test

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in both.

LiveScience

Ousted vaccine panel members say rigorous science is being abandoned

Seventeen experts ousted from a U.S. vaccine committee are expressing little faith in what the panel has become

The Independent UK

Vinay Prasad vs the FDA: How One Doctor's Policies Collided with Politics and Cost Him His Job

Vinay Prasad resigns from the FDA after backlash over vaccine restrictions and gene therapy decisions. Political pressure cited in sudden departure.

International Business Times UK

Cautious Optimism As Merck Leans On Oncology Amid Gardasil Vaccine Concerns

Pharmaceutical giants are navigating a complex landscape of fluctuating demand and regulatory hurdles, impacting their financial performance and strategic outlook. Merck Co. Inc. (NYSE:MRK) is the latest to face these challenges, as its recent earnings report reveals a mixed bag of successes and setbacks.

Benzinga

'Universal' cancer vaccine heading to human trials could be useful for 'all forms of cancer'

A new mRNA-based vaccine triggers a response from the innate immune system to help arm the body against cancer, a mouse study finds. It's now in early human trials.

LiveScience

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - US

FDA’s top vaccine official leaves post after less than four months

Trump administration gives no details about reason for departure of Vinay Prasad, but he had critics and had taken unusual actions

Benzinga

GSK Lifts Outlook As Specialty Medicines, Vaccines Fuel Growth

British pharmaceutical giant GSK Plc (NYSE:GSK) shares rose on Wednesday after reporting second-quarter results that surpassed analyst expectations and led the company to raise its full-year 2025 guidance.

The Guardian - US

US medical groups fill gap with own vaccine guides amid ‘information crisis’

As official health guidance changes, scientific groups are stepping in with evidence-based recommendations

Barchart

1 Analyst Thinks This Former Pandemic Winner Could Surge 500% This Year

This risky biotech company faces significant challenges ahead. But it has already proven its worth and may be able to do so again.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Robert Kennedy Jr Blasts Vaccine Injury Compensation Program: 'Devolved Into A Morass Of Inefficiency, Favoritism, And Outright Corruption'

Health and Human Services Secretary Robert F. Kennedy Jr. is pledging a major overhaul of the National Vaccine Injury Compensation Program, describing the system as fundamentally broken and failing its intended purpose.

We Got This Covered

RFK Jr. sets out to ‘discover’ what causes autism by September, and vaccine lawyers could get very rich from the results

Discover by autumn, sue by winter.

The Independent UK

RFK Jr. looks to boot panel that decides which HIV and cancer screenings will be free: report

Decisions from the U.S. Preventative Services Task Force impact millions of people’s access to preventative care for cancer, infectious diseases and mental health

LiveScience

Scientists gave mice flu vaccines by flossing their tiny teeth — and it worked

In a proof-of-concept study, scientists have shown that flossing your teeth could be a way to deliver vaccinations that protect you against viruses.

The Independent UK

Parents seeking religious exemptions to school vaccines win reprieve in a West Virginia county

A West Virginia judge has allowed children from three families to attend school without required vaccinations

Benzinga

Vaccine-Skeptic RFK Jr. Finalizes Ban On Mercury-Based Thimerosal In US Flu Vaccines

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. approved a major policy change on Tuesday that will remove the mercury-based preservative thimerosal from all flu vaccines distributed in the U.S.

Benzinga

Novavax Shares Promising Results For Bird Flu Vaccine, Tested In Primates

Novavax, Inc. (NASDAQ:NVAX) on Thursday revealed preclinical data from the H5N1 avian pandemic influenza vaccine candidate.

1 … 46 47 48 49

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

UK Health Security Agency

Health and Human Services

The UK Health Security Agency

213 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.